Metraipolis › archive › dc_b1bc8ecce048
Initial Dose Tarlatamab-Associated Tumour Lysis Syndrome in Small Cell Lung Cancer: A Case Report — Europe PMC PMID:42371484
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42371484
- DOI
- 10.1002/rcr2.70667
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T15:42:43.405Z
- SHA-256 of the archived text
cbc5eca84528436fbef1e2f557d82e2728a12939b4fccbde1a71d2bd014d1327- Stable URL of this page
https://metraipolis.com/documento/dc_b1bc8ecce048
How to cite
Initial Dose Tarlatamab-Associated Tumour Lysis Syndrome in Small Cell Lung Cancer: A Case Report — Europe PMC PMID:42371484 — Europe PMC (en), https://europepmc.org/article/MED/42371484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b1bc8ecce048 (Metraipolis archive dc_b1bc8ecce048, sha256 cbc5eca84528436fbef1e2f557d82e2728a12939b4fccbde1a71d2bd014d1327)
BibTeX
@misc{dcb1bc8ecce048,
title = {Initial Dose Tarlatamab-Associated Tumour Lysis Syndrome in Small Cell Lung Cancer: A Case Report — Europe PMC PMID:42371484},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42371484},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b1bc8ecce048; sha256 cbc5eca84528436fbef1e2f557d82e2728a12939b4fccbde1a71d2bd014d1327},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42371484. Agents can read the archived copy with the MCP tool read_document.